Latest Breaking News On - Percy carter - Page 4 : comparemela.com

Operator Ladies and gentlemen, thank you for standing by, and welcome to the FibroGen Fourth Quarter and Full Year 2020 Financial Results Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr. Michael Tung. Thank you. Please go ahead, sir. Michael Tung Vice President of Corporate Strategy and Investor Relations Thank you, Linda and good afternoon, everyone. I m Michael Tung, Vice President of Corporate Strategy and Investor Relations at FibroGen. Joining me on today s are Enrique Conterno, our Chief Executive Officer; Dr. Percy Carter, our Chief Scientific Officer; Pat Cotroneo, our Chief Financial Officer; Dr. Mark Eisner, our Chief Medical Officer; Thane Wettig, our Chief Commercial Officer; Chris Chung, our Senior Vice President of China Operations; and Dr. Elias Kouchakji, our Senior Vice President of Clinical Development, Drug Safety, and Pharmacovigilance. The format for today s call includes prepared remarks fro

United statesMichael tungAndy hsiehJason gerberryEdwin zhangAnnabel samimyAnnabel samimy stifelPercy carterChris chungElias kouchakjiEnrique conternoMichael yeeAmerica merrill lynchYaron werberYaron werber cowenJoel beatty citigroup